Electronic cigarettes - harmful substances contained in e-cigarette liquids and smoke
DOI:
https://doi.org/10.12775/QS.2024.16.52716Keywords
electronic cigarette, vaping, e-cigarette, cigarette smokingAbstract
Electronic cigarettes and electronic cigarette liquids are increasingly popular in society, especially among young people. However, despite the widespread belief that they are a safe alternative to traditional cigarettes, many scientific studies confirm that electronic cigarettes can be equally, if not more, harmful to health.
There are many chemicals in electronic cigarette liquids, such as nicotine, propylene glycol, glycerol, flavors and fragrances. Some of these substances are toxic and can cause a number of negative health effects, such as irritation of the respiratory tract, the onset of lung disease, neurological disorders and increased risk of cardiovascular disease.
In addition, electronic cigarettes can be harmful to the environment due to the emission of toxic substances into the air and improper disposal of used batteries.
Therefore, an informed approach to the use of electronic cigarettes and an understanding of the potential health risks associated with them is necessary. Further scientific research and education of the public about the harms of electronic cigarettes are key to preventing the negative consequences associated with their use.
References
M. Napierała, M. Kulza, A. Wachowiak, K. Jabłecka, and E. Florek, “Electronic cigarettes - effects on health. Previous reports,” Przegl Lek, vol. 71, no. 11, pp. 644–7, 2014.
K. Sharma and R. K. Jha, “Impact of Vaping on Lungs: An Indian Prospect,” Cureus, vol. 15, no. 11, Nov. 2023, doi: 10.7759/CUREUS.48281.
“America’s vaping revolution: How suspicious should we really be of the e-cigarette craze? | Salon.com.” Accessed: Jun. 12, 2024. [Online]. Available: https://www.salon.com/2014/12/07/americas_vaping_revolution_how_suspicious_should_we_really_be_of_the_e_cigarette_craze/
S. Kapoor, P. Lal, and A. Yadav, “Indirect tobacco advertising, promotion and sponsorships in the Indian Premier League 2020: Tobacco Industry’s continuous presence in Indian cricket,” Indian J Tuberc, vol. 68S, pp. S7–S13, Jan. 2021, doi: 10.1016/J.IJTB.2021.07.021.
J. Hahn et al., “Electronic cigarettes: overview of chemical composition and exposure estimation,” Tob Induc Dis, vol. 12, no. 1, 2014, doi: 10.1186/S12971-014-0023-6.
J. S. Herrington and C. Myers, “Electronic cigarette solutions and resultant aerosol profiles,” J Chromatogr A, vol. 1418, pp. 192–199, Oct. 2015, doi: 10.1016/J.CHROMA.2015.09.034.
M. Kucharska, W. Wesołowski, S. Czerczak, and R. Soćko, “[Testing of the composition of e-cigarette liquids - Manufacturer-declared vs. true contents in a selected series of products],” Med Pr, vol. 67, no. 2, pp. 239–253, 2016, doi: 10.13075/MP.5893.00365.
“SCOGS (Select Committee on GRAS Substances).” Accessed: Jun. 12, 2024. [Online]. Available: https://www.cfsanappsexternal.fda.gov/scripts/fdcc/?set=SCOGS&sort=Sortsubstance&order=ASC&startrow=1&type=basic&search=glycol
“GRAS Substances (SCOGS) Database > Select Committee on GRAS Substances (SCOGS) Opinion: Propylene Glycol and Propylene Glycol Monostearate.” Accessed: Jun. 12, 2024. [Online]. Available: https://wayback.archive-it.org/7993/20171031062706/https://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/SCOGS/ucm261045.htm
J. M. ’ ’Moline, A. L. ’ ’Golden, J. H. ’ ’Highland, K. R. ’ ’Wilmarth, and A. S. ’ ’Kao, “Health effects of evaluation of theatrical smoke, haze and pyrotechnics.,” 2000.
G. Wieslander, D. Norbäck, and T. Lindgren, “Experimental exposure to propylene glycol mist in aviation emergency training: acute ocular and respiratory effects,” Occup Environ Med, vol. 58, no. 10, p. 649, 2001, doi: 10.1136/OEM.58.10.649.
J. S. LaKind, E. A. McKenna, R. P. Hubner, and R. G. Tardiff, “A review of the comparative mammalian toxicity of ethylene glycol and propylene glycol,” Crit Rev Toxicol, vol. 29, no. 4, pp. 331–365, 1999, doi: 10.1080/10408449991349230.
Clayton GD and Clayton FE, Patty’s industrial hygiene and toxicology: Volume 2A: Toxicology, 4th ed., vol. 2E. New York: John Wiley & Sons, 1995.
“SCOGS (Select Committee on GRAS Substances).” Accessed: Jun. 12, 2024. [Online]. Available: https://www.cfsanappsexternal.fda.gov/scripts/fdcc/?set=SCOGS&sort=Sortsubstance&order=ASC&startrow=1&type=basic&search=glycerin
“GRAS Substances (SCOGS) Database > Select Committee on GRAS Substances (SCOGS) Opinion: Glycerin and Glycerides.” Accessed: Jun. 12, 2024. [Online]. Available: https://wayback.archive-it.org/7993/20171031062709/https://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/SCOGS/ucm260418.htm
O. Hernandez, “OECD SIDS DIPROPYLENE GLYCOL UNEP PUBLICATIONS 2 SIDS Initial Assessment Report for 11th SIAM”.
R. A. Renne et al., “2-Week and 13-Week Inhalation Studies of Aerosolized Glycerol in Rats,” Inhal Toxicol, vol. 4, no. 2, pp. 95–111, 1992, doi: 10.3109/08958379209145307.
W. F. Bergfeld et al., “Safety Assessment of Glycerin as Used in Cosmetics”.
V. B. Stolberg, “A cross-cultural and historical survey of tobacco use among various ethnic groups,” J Ethn Subst Abuse, vol. 6, no. 3–4, pp. 9–80, 2007, doi: 10.1300/J233V06N03_02.
J. Budzianowski, “Tobacco-once a medicinal plant. Does it contain substances with medicinal properties?,” Przegl Lek, vol. 70, no. 10, pp. 865–8, 2013.
Q. Wang et al., “Nicotine’s effect on cognition, a friend or foe?,” Prog Neuropsychopharmacol Biol Psychiatry, vol. 124, Jun. 2023, doi: 10.1016/J.PNPBP.2023.110723.
L. Ulloa, “The vagus nerve and the nicotinic anti-inflammatory pathway,” Nat Rev Drug Discov, vol. 4, no. 8, pp. 673–684, Aug. 2005, doi: 10.1038/NRD1797.
A. M. Centner, P. G. Bhide, and G. Salazar, “Nicotine in Senescence and Atherosclerosis,” Cells, vol. 9, no. 4, Apr. 2020, doi: 10.3390/CELLS9041035.
N. L. Benowitz and E. Liakoni, “Tobacco use disorder and cardiovascular health,” Addiction (Abingdon, England), vol. 117, no. 4, pp. 1128–1138, Apr. 2022, doi: 10.1111/ADD.15703.
A. Santoro et al., “Tobacco Smoking: Risk to Develop Addiction, Chronic Obstructive Pulmonary Disease, and Lung Cancer,” Recent Pat Anticancer Drug Discov, vol. 14, no. 1, pp. 39–52, Jan. 2019, doi: 10.2174/1574892814666190102122848.
A. E. Jasper, E. Sapey, D. R. Thickett, and A. Scott, “Understanding potential mechanisms of harm: the drivers of electronic cigarette-induced changes in alveolar macrophages, neutrophils, and lung epithelial cells,” Am J Physiol Lung Cell Mol Physiol, vol. 321, no. 2, pp. L336–L348, Aug. 2021, doi: 10.1152/AJPLUNG.00081.2021.
C. Schaal, J. Padmanabhan, and S. Chellappan, “The Role of nAChR and Calcium Signaling in Pancreatic Cancer Initiation and Progression,” Cancers (Basel), vol. 7, no. 3, pp. 1447–1471, Jul. 2015, doi: 10.3390/CANCERS7030845.
J. Samochowiec, D. Rogoziński, A. Hajduk, A. Skrzypińska, G. Arentowicz, and K. Klinika Psychiatrii Pomorskiej Akademii Medycznej Szczecinie, “DIAGNOSTYKA, MECHANIZM UZALEŻNIENIA I METODY LECZENIA UZALEŻNIENIA OD NIKOTYNY,” Alkoholizm i Narkomania, Tom, vol. 14, pp. 323–340.
M. Jankowski et al., “E-Cigarettes are More Addictive than Traditional Cigarettes—A Study in Highly Educated Young People,” Int J Environ Res Public Health, vol. 16, no. 13, Jul. 2019, doi: 10.3390/IJERPH16132279.
Z. Zdrojewicz, D. Pypno, B. Bugaj, and A. Burzyńska, “Elektroniczne papierosy: Wpływ na zdrowie, nikotynowa terapia zastȩpcza, regulacje prawne,” Pediatria i Medycyna Rodzinna, vol. 13, no. 1, pp. 63–71, 2017, doi: 10.15557/PIMR.2017.0006.
J. Majewski, K. Bernat, and M. J. Jarosz, “Wpływ palenia tytoniu na błonę śluzową jamy ustnej, ze szczególnym uwzględnieniem leukoplakii-na podstawie piśmiennictwa,” pp. 19–25, 2017.
K. A. Kasza et al., “Association of e-Cigarette Use With Discontinuation of Cigarette Smoking Among Adult Smokers Who Were Initially Never Planning to Quit,” JAMA Netw Open, vol. 4, no. 12, pp. e2140880–e2140880, Dec. 2021, doi: 10.1001/JAMANETWORKOPEN.2021.40880.
P. Hajek et al., “A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy,” New England Journal of Medicine, vol. 380, no. 7, pp. 629–637, Feb. 2019, doi: 10.1056/NEJMOA1808779/SUPPL_FILE/NEJMOA1808779_DATA-SHARING.PDF.
McNeill A, Brose LS, Calder R, Hitchman SC, Hajek P, and McRobbie H, “E-cigarettes: an evidence update A report commissioned by Public Health England,” 2015. Accessed: Jun. 12, 2024. [Online]. Available: www.facebook.com/PublicHealthEngland
Royal College of Physicians, “E-cigarettes and harm reduction An evidence review Executive summary and recommendations,” 2024. Accessed: Jun. 12, 2024. [Online]. Available: www.rcp.ac.uk
N. Lindson et al., “Electronic cigarettes for smoking cessation,” Cochrane Database of Systematic Reviews, vol. 2024, no. 1, Jan. 2024, doi: 10.1002/14651858.CD010216.PUB8/INFORMATION/EN.
“The Tobacco and Related Products Regulations 2016.” Accessed: Jun. 11, 2024. [Online]. Available: https://www.legislation.gov.uk/uksi/2016/507/contents
“FDA Permits Marketing of E-Cigarette Products, Marking First Authorization of Its Kind by the Agency | FDA.” Accessed: Jun. 12, 2024. [Online]. Available: https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-e-cigarette-products-marking-first-authorization-its-kind-agency
“Używanie papierosów elektronicznych przez młodzież – Poradnia narkotykowa on-line.” Accessed: Jun. 12, 2024. [Online]. Available: https://www.narkomania.org.pl/czytelnia/uzywanie-papierosow-elektronicznych-przez-mlodziez/
“E-Cigarette Use Among Youth | Smoking and Tobacco Use | CDC.” Accessed: Jun. 12, 2024. [Online]. Available: https://www.cdc.gov/tobacco/e-cigarettes/youth.html
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Konrad Białogłowski, Kamila Giżewska, Karol Bochyński, Michał Dacka, Paulina Dąbrowska, Michał Żuber, Katarzyna Molenda, Barbara Borodziuk, Filip Borodziuk, Katarzyna Ciuba
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 201
Number of citations: 0
